Literature DB >> 28062188

A comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cúcuta, Colombia.

Juan-Manuel Anaya1, Yhojan Rodríguez2, Diana M Monsalve2, Daniel Vega3, Ernesto Ojeda4, Diana González-Bravo2, Mónica Rodríguez-Jiménez2, Carlos A Pinto-Díaz2, Pablo Chaparro5, María L Gunturiz5, Aftab A Ansari6, M Eric Gershwin7, Nicolás Molano-González2, Carolina Ramírez-Santana2, Yeny Acosta-Ampudia2.   

Abstract

We have focused on the epidemiology and immunobiology of Zika virus (ZIKV) infection and factors associated with the development of Guillain-Barré syndrome (GBS) and other neurological syndromes in Cúcuta, the capital of North Santander department, Colombia. Data of patients with ZIKV disease reported to the national population-based surveillance system were used to calculate the basic reproduction number (R0) and the attack rates (ARs) as well as to develop epidemiological maps. Patients with neurological syndromes were contacted and their diagnoses were confirmed. A case-control study in which 29 patients with GBS associated with ZIKV compared with 74-matched control patients with ZIKV infection alone was undertaken. Antibodies against arboviruses and other infections that may trigger GBS were evaluated. The estimated value of R0 ranged between 2.68 (95% CI 2.54-2.67) to 4.57 (95% CI 4.18-5.01). The sex-specific ARs were 1306 per 100,000 females, and 552 per 100,000 males. A non-linear interaction between age and gender on the ARs was observed. The incidence of GBS in Cúcuta increased 4.41 times secondary to ZIKV infection. The lag time between ZIKV infection and neurological symptoms was 7 days (interquartile range 2-14.5). Patients with GBS appeared to represent a lower socioeconomic status and were living near to environmentally contaminated areas. All GBS patients were positive for IgG antibodies against both ZIKV and Dengue virus, and 69% were positive for Chikungunya virus. Noteworthy, GBS was associated with a previous infection with M. pneumoniae (OR: 3.95; 95% CI 1.44-13.01; p = 0.006). No differences in antibody levels against C. jejuni, Epstein-Barr virus and cytomegalovirus were observed. High rates of cranial nerves involvement and dysautonomia were present in 82% and 75.9%, respectively. Intensive care unit (ICU) admission was necessary in 69% of the GBS patients. Most of the patients disclosed a high disability condition (Hughes grade 4). Dysautonomia was the main risk factor of poor GBS prognosis (i.e., ICU admission and disability). Thirteen patients were diagnosed with other neurological syndromes different to GBS (6 with transverse myelitis, 3 with encephalitis, 3 with peripheral facial palsy and one with thoraco-lumbosacral myelopathy). Our data confirm an increased transmission of ZIKV in Cúcuta, and provide support to the view that severe neurological syndromes are related to ZIKV disease. The complex ways by which previous infections and socioeconomic status interact to increase the risk of GBS in people infected by ZIKV should be further investigated.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Colombia; Epidemiology; Guillain-Barré syndrome; Mycoplasma pneumoniae; Public health; Transverse myelitis; Zika virus

Mesh:

Year:  2017        PMID: 28062188     DOI: 10.1016/j.jaut.2016.12.007

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  20 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

Review 2.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

Review 3.  Current concerns and perspectives on Zika virus co-infection with arboviruses and HIV.

Authors:  Hussin A Rothan; Mehdi R M Bidokhti; Siddappa N Byrareddy
Journal:  J Autoimmun       Date:  2018-01-17       Impact factor: 7.094

4.  Guillain-Barré Syndrome and Miller Fisher Syndrome in Association With an Arboviral Outbreak: A Brazilian Case Series.

Authors:  Mateus Santana do Rosário; Pedro Antônio Pereira de Jesus; Daniel Santana Farias; Marco Antônio Caires Novaes; Marcos Vinicius Lima Oliveira Francisco; Cleiton Silva Santos; Daniel Moura; Fernanda Washington de M Lima; Luiz Carlos Junior Alcantara; Isadora Cristina de Siqueira
Journal:  Front Med (Lausanne)       Date:  2022-06-28

5.  A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika.

Authors:  Jesse H Erasmus; Amit P Khandhar; Jeff Guderian; Brian Granger; Jacob Archer; Michelle Archer; Emily Gage; Jasmine Fuerte-Stone; Elise Larson; Susan Lin; Ryan Kramer; Rhea N Coler; Christopher B Fox; Dan T Stinchcomb; Steven G Reed; Neal Van Hoeven
Journal:  Mol Ther       Date:  2018-08-02       Impact factor: 11.454

Review 6.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 7.  Neurological Implications of Zika Virus Infection in Adults.

Authors:  Laura S Muñoz; Beatriz Parra; Carlos A Pardo
Journal:  J Infect Dis       Date:  2017-12-16       Impact factor: 5.226

Review 8.  Neurological Presentation of Zika Virus Infection Beyond the Perinatal Period.

Authors:  Thomas De Broucker; Alexandra Mailles; Jean-Paul Stahl
Journal:  Curr Infect Dis Rep       Date:  2017-08-16       Impact factor: 3.663

Review 9.  Zika virus epidemiology: from Uganda to world pandemic, an update.

Authors:  C Talero-Gutiérrez; A Rivera-Molina; C Pérez-Pavajeau; I Ossa-Ospina; C Santos-García; M C Rojas-Anaya; A de-la-Torre
Journal:  Epidemiol Infect       Date:  2018-03-14       Impact factor: 4.434

10.  Zika virus-induced acute myelitis and motor deficits in adult interferon αβ/γ receptor knockout mice.

Authors:  Katherine Zukor; Hong Wang; Venkatraman Siddharthan; Justin G Julander; John D Morrey
Journal:  J Neurovirol       Date:  2018-02-23       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.